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1.Introduction
Antibiotics are among the drugs most commonly prescribed to children. It has been reported that approximately 60% of children in hospital settings (1) (2) and 20% of children in ambulatory visits receive at least one antibiotic (3) . Unfortunately, a great number of these antibiotic prescriptions are unnecessary or inappropriate. Improper antibiotic therapy is a leading factor in wasting health care resources and places patients at risk of developing adverse events and especially antimicrobial resistance. Therefore, the implementation of strategies to preserve the activity of antimicrobial agents has become an urgent public health priority. In this regard the American Academy of Pediatrics (AAP) drew up a list of 10 recommendations to be adopted in pediatric clinical practice (4) . The first of these messages discouraged the use of antibiotics in cases of apparent viral respiratory infections, because of the frequent resulting adverse events such as diarrhea and rash and especially of the spread of resistant bacterial strains (4) . Moreover, many scientific societies and government agencies joined antimicrobial stewardship initiatives that have been shown to be effective in reducing the inappropriate use of antibiotic therapy (5) .
In particular, AOM is one of the most frequent pediatric diseases: more than 80% of children under 3 years of age present at least one episode of AOM and about one-third of children has a recurrence (6-7). In Europe, the incidence of AOM in outpatient care is 268 episodes per 1000 people-year (CI 95%: 254-283) (8) and in Italy, in children under 5 years of age, is around 16% (9) . Thus, AOM is one of the most frequent indications for antibiotic therapy in children. The proportion of children with AOM treated with antibiotics ranges from about 50% in Germany (10) , to 65% in the Netherlands (11) , up to 80% in the US (12) and in Italy (13) .
Therefore, a team of experts in the management of the child's AOM from the Italian Society for Prevention and Social Pediatrics (SIPPS) has developed and proposed a top five list of recommendations on the management of AOM.
2.Methodology
A panel of experts identified, through a review of literature and consensus, five items for the list of recommendations. Once obtained the consent on the final list of five items, the statements were formulated. Drafted recommendations were formulated and then reviewed and discussed within the panel, until a final consensus was reached. Each message presented as a single, action-oriented sentence and is followed by an overview of the evidence behind the recommendation. A c c e p t e d M a n u s c r i p t
3.Results
The five most relevant messages have been summarized in Table 1 .
First message
Do not diagnose AOM without having documented the presence of middle ear effusion International literature indicates a high number of errors in diagnoses of AOM and in particular the high over-estimation of AOM frequency, often diagnosed in cases of merely hyperemic tympanic membrane or in children with otitis media with effusion (OME) (14, 15) . In order to avoid unnecessary and unjustified treatments it is therefore imperative to differentiate carefully subjects with AOM from those with OME or other forms (16, 17) .
The diagnosis of AOM cannot be based only on symptoms that are non-specific and overlapping with those of other upper respiratory tract infections. The key diagnostic element of AOM is the presence of middle ear fluid, as shown by cultures of samples obtained by tympanocentesis (18) .
The diagnostic criteria of AOM are the moderate to severe bulging of the tympanic membrane, the acute onset acute otorrhea not due to acute external otitis, the slight bulging associated with a recent onset (within 48 hours) of otalgia (ear tugging/rubbing/holding, excessive crying in the youngest child) or intense membrane hyperemia (16, 17) . The standard tool recommended by guidelines (16, 17) in diagnosing AOM is the pneumatic otoscope, which can detect the presence of endotympanic exudate more significantly than the simple otoscope. Pneumatic otoscopy allows the assessment of the contour of the TM, its color, its translucency and its mobility.
To perform a correct pneumatic otoscopy, clinicians should firstly select the speculum size that best fits the external ear canal. It is necessary to assure that the pneumatic system is leak-free by squeezing and releasing the bulb against a fingertip, in order to confirm an effective suction (16, 17) .
With the aim of getting a better view of the tympanic membrane, pediatricians should gently pull the ear backward to straighten the ear canal. The otoscope should be inserted far enough to create a good seal and to prevent air leakage between the speculum and ear canal wall. Attention should be paid not to insert the device too deeply. The ear canal and the eardrum should be carefully explored assessing color, translucency, and position of the tympanic membrane (16, 17) . A normal tympanic membrane is convex, translucent, and intact. The pneumatic procedure consists of gently squeezing the bulb in order to create positive pressure on the tympanic membrane and to observe the degree of its mobility. Subsequently, the bulb should be released to create negative pressure on the tympanic membrane and observe the degree of TM mobility.
Inward movement of the TM on positive pressure in the external canal, and outward movement on negative pressure should occur, especially in the superior posterior quadrant (16, 17) . If the Therefore, it is essential to ensure adequate instruction in the proper evaluation of the child's middle ear status and to require adequate post-graduate practice (19) .
Appropriate tools for learning ear examination can be represented by the use of video-otoscopes and of educational videos available at specific websites suggested by American guidelines (http://www2.aap.org/sections/infectdis/ video, ePROM: Enhancing Proficiency in Otitis Media) (19, 20, 21) . In uncertain cases, if a pneumatic otoscope is not available, the pediatrician could combine a simple otoscopic assessment with tympanometry, or could address the patient to the otorhinolaryngologist that uses optical microscopy, otoendoscopy or impedance measurement (16).
Second message

Do not diagnose AOM without examining the whole tympanic membrane
The main problem in AOM diagnoses is the difficulty of properly visualizing the tympanic membrane. The otoscopic assessment can be complicated or impeded by cerumen, epidermal debris or any other cause that completely or partially covers the tympanic membrane. Cerumen obstructing at least 50% of the ear canal has been described in approximately 44% of children and 52% of these children were diagnosed with AOM (22) . As highlighted in the latest guidelines, the cerumen removal is essential for the proper diagnosis and management of the AOM (16, 17) . Pediatricians can remove it by irrigation of the ear canal with warm water (with a syringe of 10-20 mL).
Alternatively, only if performed by experienced hands and using a surgical head otoscope, it is possible to remove cerumen by using a curette with a loop (Billeau curette) or speculums equipped with a small hook (16, 22) . Currently, there are plastic curettes illuminated by a small light source and not completely obstructing the ear canal; these devices, even without a necessary specific experience, make it possible to remove the "soft" cerumen. This practice needs head immobilization in order to prevent ear canal skin lesions and bleeding, that may be abundant during crying, and that may obstruct tympanic membrane visualization, other than alert the pediatrician and parents. A few drops of 10% hydrogen peroxide, instilled and left into the ear canal for two or three minutes, make the cerumen softer. Alternatively, if necessary, cerumen removal may require the intervention of the otorhinolaryngologist. An explanatory video with all the details on removal practice is available on the website of the New England Journal of Medicine (22, 23) . A c c e p t e d M a n u s c r i p t
Third message:
Do not treat immediately all cases of AOM with antibiotics. Considering the risk-benefit ratio, guidelines recommend the "wait and see" strategy in children aged from 6 months to 2 years with unilateral AOM and mild symptoms and signs and in children of 2 years and older with unilateral AOM (either mild or severe) or bilateral with mild signs and symptoms.
On the other hand, an immediate antibiotic therapy is always recommended in children younger than 2 years with bilateral (both severe and mild) AOM, in children older than 2 years with severe bilateral AOM, in those with othorrea from spontaneous perforation and those with a history of recurrence (16, 17) . In addition, antibiotic treatment is reasonably advisable in children under 2 years of age with severe symptoms, when a certain AOM diagnosis is not achievable, even performing all diagnostic procedures (16, 17) .
Metanalysis and controlled randomized trials (24, 25) demonstrated a greater benefit of the immediate antibiotic therapy in terms of pain and fever reduction in cases of bilateral AOM in children under 2 years of age and in children with associated othorrea. Compared with subjects with unilateral AOM, cases with bilateral AOM are more likely to be of bacterial etiology (25, 26) , and the age under two years is associated with slower spontaneous resolution and higher rate of clinical failure (27) . This strategy is also confirmed by the results of a recent randomized, double blind, placebo-controlled study including children aged 3 to 35 months with a certain diagnosis of AOM, aimed at assessing the effect of antibiotic therapy on the resolution time of the middle ear effusion. A c c e p t e d M a n u s c r i p t (AOM, OME, and normal middle ear status) and appropriately changed according to the clinical evolution (32). These scales have the limit of not attributing to each item a different weight based on its prognostic value. At this regard, it is interesting to point out the scale proposed by the Japanese guideline (33) , which assigns different scores to the following parameters: age, otalgia intensity, fever, crying, hyperemia or bulging of the tympanic membrane, otorrhea. Even if the Japanese score seems to be a more versatile tool, at the moment there is no evidence of superiority of a severity score on the others.
The "wait and see" strategy should be adopted only if an adequate follow-up is feasible. Moreover, antibiotic should be prescribed in children with clinical worsening or not improving within 48 to 72 hours (16, 17) . Parents/tutors should be advised about the benign and self-limiting nature of most AOMs. (16, 17) . The follow-up procedure has not been yet standardized and remains at the discretion of the physician, who may decide to schedule a check-up visit, establish a telephone contact, or prescribe an antibiotic therapy to be administered in case of clinical worsening. A randomized placebo-controlled Finnish study on children aged 3 to 35 months with AOM diagnosis showed that changes in otoscopic MT appearance were related (86%) to the parental clinical report (AOM-SOS). Therefore, children with reported clinical improvement may not need a routine checkup visit but a phone follow-up may be sufficient (34).
Fourth message
Do not administer ear analgesic drops until examining the whole tympanic membrane
The management of AOM should include assessment and treatment of otalgia. Paracetamol or ibuprofen could be used (16, 17, 35, 36) . The use of anesthetic eardrops can be considered only in combination with systemic analgesic therapy, in case of moderate to severe otalgia, as they have the advantage of controlling pain more rapidly than systemic analgesics. Analgesic drops can be applied only after tympanic membrane assessment and after excluding a tympanic perforation as they may complicate global tympanic membrane visualization (16). A potential strategy for reducing the spread of antibiotic resistance could be to shorten the duration of therapy below the standard 10 days (17, 37) . Studies comparing the efficacy of 10 days antibiotic therapy (amoxicillin, trimethoprym sulphamethoxazole, cephalosporin and macrolides) with that of 5 -7 days regimen did not show any significant differences except for a minimal superiority of prolonged duration in children younger than 2 years (37) or in children with history of AOM in the previous month or at risk of bacterial resistance (38) [16%]) with a difference of 17% (27) . On the other hand, there was no significant difference between the two groups in terms of risk of monthly recurrence, of residual middle ear effusion frequency, of adverse events, and especially in terms of the onset of resistant bacteria during or after therapy (27) .
Fifth message
Do not use macrolides in the AOM therapy
Therefore, antibiotic therapy should last 10 days in children at risk of worsening (less than 2 years and / or with spontaneous otorrhea), while 5 days therapy may be adopted in children younger than 2 years without risk factors for unfavorable evolution (16, 27) .
Macrolides have limited efficacy against AOM pathogen bacteria (S.pneumoniae, H.influenzae, M. catarrhalis), since antibiotic resistance rates widely varies between countries and in Europe a figure of 26% for S. pneumoniae and 38% for S. pyogenes is described (40) . Macrolides should be used only in children allergic to penicillins. Cross reactivity between penicillin and second or third generation cephalosporins is negligible, due to the different chemical structure (41) . On the other hand, it has been shown that the use of third generation cephalosporins leads to the selection of resistant strains such as extended-spectrum beta lactamase (ESBL) Enterobacteriaceae (42, 43) . 
Conclusions
The main objective of proposing these five messages is to promote a correct use of antibiotics in AOM management. The therapeutic choice is possible only after visualization of the entire tympanic membrane with the technique and instrumentation recommended by the guidelines.
Antibiotics should be used only when watchful waiting strategy is not feasible such as in children younger than 2 years with bilateral otitis, in children older than 2 years with serious bilateral symptoms, in those with otorrhea and with recurrence history.
Expert commentary
The key weaknesses in the management of AOM are the difficulties of distinguishing AOM from OME from TM hyperemia, and of selecting patients who need antibiotic therapy from those eligible for the watchful waiting strategy. Moreover, there are not standardized AOM severity scores or a definite follow-up procedure by pediatricians. Recent guidelines have established rigorous diagnostic criteria and have offered precise categories of patients to guide the choice between immediate antibiotic therapy and watchful waiting strategy (16, 17) . Such selection results from consideration of patient's characteristics such as age, bilateral or monolateral AOM, clinical severity, epidemiology, prior antibiotic therapy. Unfortunately, little adherence to the guidelines' recommendations has been reported, as shown by the high percentage of antibiotic prescription (44) . Therefore, it is essential to provide physicians with readily available tools to facilitate the acquisition of diagnostic and therapeutic criteria. This list of recommendations could be a valuable instrument thanks to its synthetic ability and clear presentation of supporting evidences. It is also essential to institute education courses on the inspection of the tympanic membrane, the use of the pneumatic otoscope, the impedance-measuring device other than the technique to remove cerumen from the external auditory duct. Nevertheless, incisive campaigns to promote parents' awareness of proper antibiotic should be warranted.
When an antibiotic therapy is required, the first choice drug should be amoxicillin The most recent research has focused on establishing the appropriate duration of therapy (37) (38) (39) .
Several studies compared standard duration therapy with lower duration therapy. The results were discordant and did not show significant differences unless a minimum superiority of prolonged duration in children under the age of 2 years (37) or in children with history of AOM in the previous month or at risk of resistant infections (38) . Interestingly, Hoberman's 2016 study (27) showed higher percentage of clinical failure in children treated for 5 days without significant differences about the side effects and the occurrence of resistant bacteria either in course or after the therapeutic cycle. Therefore, the certain effective strategies able to contain antibiotic resistance are the correct diagnosis of AOM and the precise selection of the patients to treat but not to shorten therapy duration, unless in very limited cases, whose definition still needs further studies.
Current research is also focusing on validating severity scores of AOM and follow up strategies. A randomized placebo-controlled Finnish study (34) on children aged 3 to 35 months with AOM showed that the improvement in the otoscopic examination findings correlates well (86%) with the clinical report described by parents with the AOM-SOS score.
Therefore, in children with clinical improvement reported by parents, a routine scheduled follow-up appointment may not be required, but a telephone follow-up may be sufficient (34) .
A recent Cochrane review has evaluated the effects of advising a delayed prescription of antibiotics in respiratory tract infections (including three studies on AOM) on clinical outcomes, antibiotic use, antibiotic resistance and patient satisfaction (45). The study has shown that a delayed antibiotics strategy may be an acceptable compromise in place of immediate prescribing to significantly reduce unnecessary antibiotic use for RTIs, and thereby reduce antibiotic resistance, while maintaining patient safety and satisfaction levels (45).
Five-year view
Looking forward over the next 5 years, significant advances are expected in clinical research in these regards that may extensively impact the quality of AOM management.
A further diffusion in the everyday clinical practice of pneumatic otoscopy and of cerumen removal is desirable. Indeed, we believe that the standardization of severity scores and follow up procedures could give greater solidity and security to the watchful waiting strategy leading to greater adherence to this approach. A c c e p t e d M a n u s c r i p t
Key issues
• AOM is one of the most frequent indications for antibiotic therapy in children.
Unfortunately, a great number of these antibiotic prescriptions are unnecessary or inappropriate.
• In order to avoid unjustified treatments it is imperative to differentiate carefully subjects with AOM from those with OME or other forms.
• The key diagnostic element of AOM is the presence of middle ear fluid. The standard tool recommended by guidelines in diagnosing AOM is the pneumatic otoscope.
• With the aim of visualizing the whole tympanic membrane it is essential to remove cerumen from the external auditory canal.
• The "wait and see" strategy is recommended in children aged from 6 months to 2 years with unilateral AOM and mild symptoms and signs and in children of 2 years and older with unilateral AOM (either mild or severe) or bilateral with mild signs and symptoms.
• The "wait and see" strategy should be adopted only if an adequate follow-up is feasible.
• Analgesic drops can be applied only after tympanic membrane assessment and after excluding a tympanic perforation.
• Macrolides have limited efficacy against AOM pathogen bacteria. Therefore, they should be administered only in cases of severe allergy to penicillins and cephalosporins.
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